[2026 update] Documenting an adverse event properly

Documenting an adverse event properly Writing it up because I had to work it out twice and would rather nobody else did.

Asking about Documenting an adverse event on behalf of the question I keep seeing asked badly, including by me.

Framed properly it is answerable. Framed the usual way it is not, and that is most of why the previous threads went nowhere.

Trying to state the Documenting an adverse event position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.

I read the opening post twice before replying, because I had assumed the opposite.

Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2. Rodent toxicology showed a signal; human evidence of causation is absent but caution is appropriate.

I would put the burden of proof on the interesting explanation, not the dull one.

Appreciated. The plain phrasing does more work here than a longer post would.

On the opening post — agreed on the reasoning, with one qualification.

Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.

The answer changed when I changed how I was measuring, which was informative.

The strongest argument against my own position on Documenting an adverse event, stated as well as I can state it, since nobody else has yet.

Thank you — that answers what I came here to find out.

Picking up post #5: that is the part I would want checked first.

Documenting an adverse event would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

Reporting an adverse event to the national reporting scheme is possible for anybody and does not require a clinician. Those schemes exist to catch what trials could not.

That holds for the case as described. Change the assumptions and it may not.

Post #9 is right about the mechanism and I think understates the practical bit.

Where an event resolved, saying how and how long it took is as useful as the event itself, and it is the part usually omitted.

I would be interested in a counterexample if anyone has one.

Post #10 answers the question as asked. The question underneath it is different.

The reason Documenting an adverse event is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.

Good question, well framed, and I would like to see it answered properly.

Practical experience of Documenting an adverse event, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.

Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears, stopping the drug and seeking urgent evaluation is appropriate.

The literature is thinner on this than the confidence in the thread implies.